LABORATORY CORP OF AMERICA HOLDINGS Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LABORATORY CORP OF AMERICA HOLDINGS for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 75.63 | 5,300 | 400,839 | 0 | |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.72 | 367 | 52,378 | 12,908 | 13.3 K to 12.9 K (-2.76 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.70 | 100 | 14,270 | 13,275 | 13.4 K to 13.3 K (-0.75 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.69 | 2,000 | 285,380 | 13,375 | 15.4 K to 13.4 K (-13.01 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.69 | 2,633 | 375,693 | 15,375 | 18 K to 15.4 K (-14.62 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.68 | 200 | 28,536 | 18,008 | 18.2 K to 18 K (-1.10 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 75.63 | 5,300 | 400,839 | 18,208 | 12.9 K to 18.2 K (+41.06 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 75.63 | 1,000 | 75,630 | 3,300 | |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 75.63 | 1,000 | 75,630 | 4,300 | |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 77.58 | 992 | 76,959 | 0 | |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 75.63 | 1,000 | 75,630 | 16,832 | 15.8 K to 16.8 K (+6.32 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 140.00 | 1,000 | 140,000 | 15,832 | 16.8 K to 15.8 K (-5.94 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 75.63 | 1,000 | 75,630 | 16,832 | 15.8 K to 16.8 K (+6.32 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 140.00 | 992 | 138,880 | 15,832 | 16.8 K to 15.8 K (-5.90 %) |
| Feb 27 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 77.58 | 992 | 76,959 | 16,824 | 15.8 K to 16.8 K (+6.27 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 603 | 0 | 10,941 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 133.83 | 244 | 32,655 | 4,039 | 4.3 K to 4 K (-5.70 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 603 | 0 | 4,283 | 3.7 K to 4.3 K (+16.39 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 450 | 0 | 2,990 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 133.83 | 138 | 18,469 | 3,230 | 3.4 K to 3.2 K (-4.10 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 450 | 0 | 3,368 | 2.9 K to 3.4 K (+15.42 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 17,790 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 133.83 | 2,013 | 269,400 | 4,127 | 6.1 K to 4.1 K (-32.79 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 6,140 | 40 to 6.1 K (+15,250.00 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 520 | 0 | 3,491 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 133.83 | 188 | 25,160 | 18,398 | 18.6 K to 18.4 K (-1.01 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 520 | 0 | 18,586 | 18.1 K to 18.6 K (+2.88 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,046 | 0 | 21,712 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,830 | 0 | 24,758 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 133.83 | 1,004 | 134,365 | 11,534 | 12.5 K to 11.5 K (-8.01 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 3,046 | 0 | 12,538 | 9.5 K to 12.5 K (+32.09 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 133.83 | 606 | 81,101 | 9,492 | 10.1 K to 9.5 K (-6.00 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,830 | 0 | 10,098 | 8.3 K to 10.1 K (+22.13 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,046 | 0 | 10,164 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 13,210 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 133.83 | 999 | 133,696 | 4,530 | 5.5 K to 4.5 K (-18.07 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,046 | 0 | 5,529 | 2.5 K to 5.5 K (+122.67 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 133.83 | 172 | 23,019 | 2,483 | 2.7 K to 2.5 K (-6.48 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 2,655 | 2.2 K to 2.7 K (+20.41 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,543 | 0 | 48,245 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 133.83 | 2,496 | 334,040 | 137,192 | 139.7 K to 137.2 K (-1.79 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,543 | 0 | 139,688 | 132.1 K to 139.7 K (+5.71 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Buy | M | 0.00 | 1,560 | 0 | 1,560 | 0 to 1.6 K |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,560 | 0 | 6,034 | 4.5 K to 6 K (+34.87 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,560 | 0 | 6,973 | 5.4 K to 7 K (+28.82 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,560 | 0 | 6,468 | 4.9 K to 6.5 K (+31.78 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 133.83 | 156 | 20,877 | 31,943 | 32.1 K to 31.9 K (-0.49 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,560 | 0 | 32,099 | 30.5 K to 32.1 K (+5.11 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,560 | 0 | 15,832 | 14.3 K to 15.8 K (+10.93 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,560 | 0 | 4,924 | 3.4 K to 4.9 K (+46.37 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,560 | 0 | 12,908 | 11.3 K to 12.9 K (+13.75 %) |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
| Feb 13 2017 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Buy | M | 0.00 | 1,560 | 0 | 4,472 | 2.9 K to 4.5 K (+53.57 %) |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 130.60 | 3,700 | 483,220 | 3,700 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 980 | 0 | 11,544 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 130.60 | 21,300 | 2,781,780 | 21,300 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 5,590 | 0 | 23,890 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 130.60 | 11,400 | 1,488,840 | 11,400 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,980 | 0 | 26,588 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 130.60 | 3,400 | 444,040 | 3,400 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 0.00 | 890 | 0 | 4,011 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 130.60 | 2,800 | 365,680 | 2,800 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 0.00 | 740 | 0 | 3,440 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 130.60 | 3,400 | 444,040 | 3,400 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 890 | 0 | 13,660 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 130.60 | 48,300 | 6,307,980 | 48,300 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 12,660 | 0 | 55,788 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
| Feb 09 2017 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 |